Serum CA19-9 is a significant predictor among preoperative parameters for early recurrence after resection of pancreatic adenocarcinoma.

摘要

To evaluate the preoperative factors predictive of postoperative early recurrence in patients with resected pancreatic cancer focusing on the serum CA19-9 value.One hundred fifty-four patients undergoing surgical resection for pancreatic cancer were enrolled in this study. Univariate and multivariate analyses were performed to determine the predictors of early recurrence which was defined as relapse within 6?months after surgery.On ROC curve analysis, the cutoff value of CA19-9 was determined to be 100?U/ml. Of 73 patients with CA19-9 value?≥?100?U/ml, 39 (53?%) had early recurrence. In contrast, only 9 of 81 patients (11?%) with CA19-9 value?